We measured CBF and the CMRglc in normal controls and in patients with severe liver disease and ev idence for minimal hepatic encephalopathy using positron emission tomography. Regions were defined in frontal, temporal, parietal, and visual cortex; the thalamus; the caudate; the cerebellum; and the white matter along with a whole-slice value obtained at the level of the thalamus. There was no difference in whole-slice CBF and CMRglc values. Individual regional values were normalized to the whole-slice value and subjected to a two-way repeated measures analysis of variance. When normalized CBF and CMRglc values for regions were compared between groups, significant differences were demonstrated (F = 5.650, p = 0.00014 and F = 4.58 , p = 0.0073, respec-
Summary:
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To date, most studies of the pathophysiology of hepatic encephalopathy have focused on elucidat ing mechanisms by which various putative toxins tively). These pattern differences were due to higher CBF and CMRglc in the cerebellum, thalamus, and caudate in patients and lower values in the cortex. Standardized co efficients extracted from a discriminant function analysis permitted correct group assignment for 95.5% of the CBF studies and for 92.9% of the CMRglc studies. The similar ity of the altered pattern of cerebral metabolism and flow in our patients to that seen in rats subjected to portacaval shunts or ammonia infusions suggests that this toxin may alter flow and metabolism and that this, in turn, causes the clinical expression of encephalopathy. Key Words: Positron emission tomography-Cerebral blood flow Cerebral glucose metabolism-Hepatic encephalopa thy-Ammonia. such as ammonia, endogenous benzodiazepine ligands, mercaptans, short-chain fatty acids, and others affect brain function (Lockwood, 1987; But terworth and Layrargues, 1989) . Little attention has been paid to the effects of these toxins on speci fi c brain regions.
Studies of CBF and CMR gl c in humans with liver disease have generally been confined to whole brain measures and, in general, have shown little or no abnormality of flow or metabolism in asymptom atic subjects, reductions in blood flow in comatose subjects, and normalization of flow and metabolism after successful treatment (Lockwood, 1987) . Al though Rodriguez et ai. (1987) used regional probes in their Xe-133 study of CBF, they reported their results only as a reduction in hemispheric or global flow.
We have used positron emission tomography (PET) to measure CBF and CMR glc in normal controls and in patients requiring hospitalization because of severe liver disease, most of whom ex hibited minimal but definite abnormalities on neuro-logical examination. We report significant abnor malities in the pattern of flow and metabolism in the patients with liver disease. A preliminary account of this work has been presented (Lockwood and Yap, 1989) .
METHODS

Patient selection
Informed consent was obtained from patients and nor mal control subjects using protocols and procedures ap proved by the University of Texas Health Science Center at Houston Committee for the Protection of Human Sub jects. Control subjects were free of known diseases of the liver and the central nervous system and were not taking any medications known to affect the brain. Patients had been admitted to the hospital because of the effects of liver disease: usually gastrointestinal hemorrhage due to ruptured esophageal varices or increasing ascites. Cor roborating laboratory evidence for severe liver disease such as elevation of serum transaminases, hyperbiliru binemia, hypoalbuminemia, or prolongation of the pro thrombin time was required for all patients. Patients with active infections, hepatorenal syndrome, diabetes melli tus, or other major nonhepatic or central nervous system diseases were excluded. Hospital records were reviewed, and patients were examined by a neurologist (A.H.L.).
General procedures
A radial artery was catheterized and irrigated continu ously with heparinized saline and an intravenous infusion begun when necessary. The head was positioned so that the canthomeatal lines were parallel to the image planes of the positron camera. Plasma glucose concentrations were measured with a Beckman Glucose Analyzer II, and arterial ammonia concentrations with a DuPont ACA II autoanalyzer.
Scanning procedures
Imaging was performed with the University of Texas positron camera (Mullani et aI., 1982 (Mullani et aI., , 1984 . This system records data from nine image planes simultaneously with an in-plane reconstructed resolution of 13-14 mm (full width at half-maximum) and 10 mm in the axial plane. The center-to-center distance between adjacent image planes is 10.8 mm. Corrections for photon attenuation in the head were made by assuming a uniform tissue density in each slice and using a brief transmission scan to define the head boundary, a procedure adopted to minimize total time in the PET camera for ill, uncomfortable subjects. Random coincidence corrections were made in the emis sion data using the background subtraction technique in the projection data. The camera and well counter, used to measure blood activity, were cross-calibrated on the day of each study.
Physiological measurements
CBF was calculated using the in vivo autoradiographic method, accounting for decay of the isotope during the imaging period and the time delay that separates arrival of the tracer in the brain and the radial artery (Ginsberg et aI., 1982; Howard et aI., 1983; Lockwood et aI., 1983) using [150] water as the tracer (West and Dollery, 1961) .
CMRglc was calculated using e8F]2-fluoro-2-deoxyglu cose (FDG) (Tewson, 1989) and the Sokoloff equation (Sokoloff et aI., 1977) with standard values for the rate constants and the lumped constant (Phelps et aI., 1979) . A 15 min image was used, with acquisition beginning 40 min after the FDG injection.
Calculations and statistical analysis
Symmetrical regions of interest were drawn on struc tures from the right and left side of the brain as follows: in the slice where cerebellar size was the greatest, the cer ebellar hemispheres; in the slice containing the thalamus and head of the caudate, the frontal, temporal, parietal, and occipital cortex, the thalamus, the head of the cau date, and the entire slice; and in a slice containing the centrum semiovale, the white matter. Absolute values for CBF and CMRglc were extracted and the means of the right and left side were computed and tabulated. Each regional value was normalized by dividing the value for the region by the value for the whole slice.
A two-way, repeated-measures analysis of variance was conducted for normalized CBF and CMRglc values using group (control vs. patient) and brain region as the independent variables. In these computations, all regions within a group were combined in the search for between group differences, all regional values for both groups were combined in the search for regional differences, and all values for each region within each group were com bined and compared with regional values from the other group in the search for region-by-group differences. A discriminant function analysis was conducted using nor malized regional values for CBF and CMRglc, using pro grams from the Statistical Package for the Social Sciences Personal Computer Plus (SPSS, 1986) .
RESULTS
A total of II sets of CBP data and 6 sets of CMR g lc data were obtained from control subjects and 11 sets of CBP and 8 sets of CMR g lc data were obtained from patients with liver disease. Some subjects had CBP or CMR g lc only measured while some had both measurements made. CBP data from the accompanying paper are included in this analy sis (Lockwood et al., 1991) . One patient had an end to-side portacaval shunt constructed to treat Budd Chiari syndrome, one had viral hepatitis, and the others had cirrhosis, with one being diagnosed only because of a laparotomy to remove a ruptured spleen. Two patients had been receiving treatment for hepatic encephalopathy but were regarded as being nearly normal by their treating physicians. With these exceptions, other subjects were judged as being free of encephalopathy by their primary physicians. On neurological examination, only the patient with hepatitis and another admitted for sple nectomy were judged to be completely free of en cephalopathy. All others had very subtle signs of cerebral dysfunction that included slight lethargy, confusion about dates, difficulty in performing se rial sevens, slight asterixis, increased muscle tone, increased deep tendon reflexes, or extensor plantar signs.
The arterial blood pH was significantly more al kalotic and the ammonia concentration was signifi cantly higher in the patients than in the controls, as shown in Table 1 . Whole-slice CBF and CMR g lc values were no different in these groups, as shown in Table 1 . Accordingly, normalized regional values for CBF and CMR g lc were used for further statisti cal analyses.
The results of the analysis of variance conducted on normalized CBF and CMR g lc data are shown in Table 2 . The only nonsignificant comparison was that for between-group differences in CBF. All other comparisons were significant at least at the p = 0.0 12 or less level. Thus, for both CBF and CMR g l c , there is a highly significant difference in the pattern of flow and metabolism even though there is no overall difference in whole-slice CBF and CMR g lc These differences are attributable to a redistribution of CBF and CMR g lc from the cortex to the caudate, thalamus, and cerebellum as shown in Figs. I and 2 .
The values of the standardized canonical discrim inant function coefficients are shown in Table 3 . The larger the absolute value of the coefficient, the more useful that the normalized CBF or CMR g lc value is in making the discrimination between nor mal subjects and patients. These coefficients were then used, along with a constant generated during the analysis (values not shown), to predict group segregation and to compare the predicted group with the known actual group. The results of the predictions based on CBF are shown in Table 4 , wherein 95.5 of all predictions were correct (chance-corrected kappa = 90.9%). The predic tions based on the CMR g lc are shown in Table 5 . Although a single patient was classified as a control, for a correct classification in 92.9% of all cases (kappa = 85.7%), there was no actual overlap of the groups' distributions. If we had adjusted the value of the constant, a completely correct classification would have followed. However, since that result would pertain to this data set only, and would not generalize to a larger data set, we report the more general classification result, as shown in Table 5 . (Greenhouse and Geisser, 1959) , which corrects for com pound symmetry violations in ANOVA.
DISCUSSION
Although disordered cerebral function has been associated with severe liver disease for over a cen tury, the literature contains little specific informa tion concerning which aspects of cerebral function are affected and even less concerning the disrup tions in neurophysiological function that must nec essarily underlie the clinical manifestations of en cephalopathy. Neuropsychological studies have shown a selective vulnerability of some functions, most notably those associated with perceptual mo tor activities, with relative preservation of intellec tual, language, memory, and learning abilities (Rik kers et aI., 1978; Gilberstadt et aI., 1980; McClain et aI., 1984; Tarter et aI., 1984 Tarter et aI., , 1986 Gitlin et aI., 1986; Morgan et ai., 1989) . In this study, we have shown that there are significant differences in the patterns of CBF and CMR g lc in patients with severe liver disease who exhibit minimal evidence for en cephalopathy as shown by a standard neurological examination. These regional physiological differ ences are highly significant, as shown by an analy sis of variance. CBF and CMR g lc data alone are sufficient to permit correct assignment to a control or patient group about 95% of the time, as shown by a discriminate function analysis.
Our data show a redistribution of flow and me tabolism from various cortical regions to subcorti cal grey matter regions and the cerebellum, as shown in Figs. 1 and 2 . These data are similar to the pattern of redistribution of glucose metabolism measured in rats after portacaval shunt-induced hy perammonemia, or after the infusion of small amounts of ammonia into the carotid artery of nor mal or portacaval-shunted rats (Lockwood et aI., 1986) . In the animal study, we found that glucose metabolism was increased in the caudate-putamen, thalamus, and other subcortical grey matter re gions, relative to metabolic rates measured in vari ous cortical regions (Lockwood et aI., 1986) . The cerebellum was not included in that study. Since the pattern of the abnormality produced by an acute short-term exogenous ammonia load delivered to the brain closely resembled that seen in rats with chronic portacaval shunt and hyperammonemia, we suggested that the alteration of metabolism was due to the effects of ammonia on the brain (Lockwood et aI., 1986) . The data from this study provide the first evi dence, to our knowledge, for regional abnormalities of CBF and CMR g l c in patients with severe liver disease and minimal cerebral dysfunction. Although the data were collected in a nonactivated state, we believe that it is reasonable to hypothesize that they represent the relative degree of cerebral function in the resting state and possibly the capacity for brain Table 3 for details) showed that the pattern of regional CBF differed significantly between the groups.
regions to become involved in the conduct of vari ous tasks.
Hepatic encephalopathy is associated with quan titative and qualitative abnormalities of conscious ness. Usually, the level of consciousness is thought of as a function of the reticular activating system; however, dysfunction or disconnection of the entire cortex from this midbrain center is also associated with a reduction in alertness. The relative depres sion of all cortical regions sampled is consistent with the reduction in the alertness of patients with hepatic encephalopathy and the slight lethargy ob served in most of our subjects.
Since the cerebral dysfunction associated with metabolic disturbances is usually attributed to ab- . 1 and 2 and Tables 3-5) IS somewhat unexpected. However, since patients with hepatic encephalopathy do have abnormalities of the motor system, involvement of the basal gan glia might be expected. In addition to its importance in the extrapyramidal system, the neostriatum and, in particular, the caudate are important in the con trol of sensory information (Schneider, 1984) and abnormalities of this function may be present in these patients, as suggested by neuropsychological test results. Schneider (1984) has reviewed the role of the basal ganglia in the regulation of behavior, with par ticular emphasis on the caudate nucleus. He dis cussed three major functions: the analysis of sen sory information for other systems, such as the mo tor system; the regulation of the ease with which sensory afferent impulses gain access to efferent systems; and modulation of sensory proces � i � g at brainstem, thalamic, and cortical levels. Additional insight has come from pharmacological stimulation of the striatum with apomorphine, which enhances the ability of rats to select strategies using cues that are intrinsic to the animal (Cools, 1980) . Recovery from lesions placed in the mesotelencephalic dopa minergic projections in rats is associated with a nor malization of deoxyglucose uptake by the caudate putamen (Koslowski and Marshall, 1981) . The in crease in caudate CBF and CMR g lc we observed could be associated with a removal of inhibitory influences, or possibly an attempt to compensate for reduced cortical activity by an increase in the activity of the monitoring and information process ing function of this nucleus.
Although the data from this study do not suggest a mechanism to cause the changes in the pattern of CBF and CMR g lc, we are struck by the similarity � f the pattern we observed in this study to that prevI ously reported in rats with acute or chronic hyper ammonemia (Lockwood et aI., 1986) . In an accom panying paper, we report that patients with severe liver disease and mild hyperammonemia have an increase in the permeability-surface area product to ammonia at the blood-brain barrier that enhances the entry of ammonia into the brain (Lockwood et aI., 1991) . This suggests that the impact of hyper ammonemia on the brain may be greater than that predicted on the basis of the arterial ammonia con centration. Thus, ammonia may cause the func tional and physiological abnormalities we observed. If this hypothesis is correct, more vigorous mea sures designed to detect and treat mild hyperam monemia seem warranted. This hypothesis is sup ported by reports that neuropsychological test ab normalities are normalized after the treatment of minimal encephalopathy (McClain et aI., 1984; Morgan et aI., 1989) .
